Biotech

All Articles

Merck's LAG-3 combination fails colon cancer cells phase 3 study

.An attempt through Merck &amp Co. to unlock the microsatellite stable (MSS) metastatic intestines c...

Spanish VC closes $200M life scientific researches fund

.Spain-based Asabys Allies has actually closed a fund of 180 million euros ($ 200 million), money th...

BioAge introduces $198M from IPO as excessive weight biotech participates in Nasdaq

.BioAge Labs is introducing practically $200 thousand through its own Nasdaq IPO this morning, with ...

Acadia delivers BMS vet on board as CEO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings...

Cassava pays for $40M over presumably misleading Alzheimer's update

.Cassava Sciences has agreed to pay for $40 million to address an inspection into cases it made dece...

Merck bags alternatives on Evaxion's AI-designed vaccine prospects

.Merck &amp Co. has gotten alternatives on pair of Evaxion Biotech injection candidates, paying out ...

Enanta's RSV antiviral crushes popular lots in challenge research study

.Enanta Pharmaceuticals has actually linked its own respiratory system syncytial virus (RSV) antivir...

Biogen canisters SAGE-324 partnership after vital shake fail

.Biogen has conducted the last rites to its partnership with Sage Therapeutics on SAGE-324, breaking...

AbbVie Parkinson's medication from $8.7 B Cerevel acquistion scores

.On the same time that some Parkinson's illness medicines are being disputed, AbbVie has introduced ...

Arch shuts $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund from Bain Funding Life Sciences, Arch Project Partners is actuall...